LC - I understand, we can forget things, especially when we keep weaving a maze of meaningless points in the final analysis. Please be reminded, LL's successful combo trials use DCVAX as SOC. No chemo-rad. As I've mentioned, it's chemo-rad, which is responsible for cancer recurrence by year five in 49 - 69% of the most deadliest cancers.
Market Data 
Markets 
AI
